Research demonstrates siRNA knockdown of Meox1 reduces tumor proliferation and enhances CD8 T cell activity in lung cancer, indicating its importance in tumor immunity.
Key Points
siRNA-mediated knockdown of meox1 significantly impairs tube formation in endothelial cells and reduces tumor proliferation, highlighting its role in lung cancer progression.
In an animal model, reduced meox1 expression resulted in increased CD8 T cell activity, suggesting a potential for enhancing immune responses against tumors.
Transcription factor dynamics were mapped using single-cell RNA sequencing, revealing insights into gene regulatory networks in lung tumor and immune cells.
Findings support potential targeted therapies to restore endothelial function and improve immune response in lung cancer treatment.